1.5K
$100M$1B
4.8K$1B
43$10M
334$50M$100M
51$10M$50MZiopharm Oncology uses 8 technology products and services including Akamai, Drupal, React, and more. Explore Ziopharm Oncology's tech stack below.
| Ziopharm Oncology Email Formats | Percentage |
| FLast@ziopharm.com | 77% |
| Last@ziopharm.com | 21% |
| First.Last@ziopharm.com | 2% |
| FLast@alaunos.com | 92% |
| First@alaunos.com | 8% |
Biotechnology ResearchTexas, United States51-200 Employees
Alaunos Therapeutics is a clinical-stage oncology-focused cell therapy company, focused on developing T-cell receptor (TCR) therapies based on its proprietary, non-viral Sleeping Beauty gene transfer platform and its unique cancer mutation hotspot TCR library, targeting common tumor-related mutations in key oncogenic genes including KRAS, TP53 and EGFR.
Company Overview
Media & News
Funding & FinancialsZiopharm Oncology has raised a total of $8.4M of funding over 8 rounds. Their latest funding round was raised on Sep 13, 2019 in the amount of $8.4M.
Funding & FinancialsZiopharm Oncology has raised a total of $8.4M of funding over 8 rounds. Their latest funding round was raised on Sep 13, 2019 in the amount of $8.4M.
1-888-653-2347 
support@leadiq.com